Your browser doesn't support javascript.
loading
Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity.
Rao Muvva, Jagadeeswara; Ahmed, Sultan; Rekha, Rokeya Sultana; Kalsum, Sadaf; Groenheit, Ramona; Schön, Thomas; Agerberth, Birgitta; Bergman, Peter; Brighenti, Susanna.
Afiliación
  • Rao Muvva J; Center for Infectious Medicine (CIM), Department of Medicine, ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Ahmed S; Clinical Microbiology, Department of Laboratory Medicine (Labmed), ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Rekha RS; Clinical Microbiology, Department of Laboratory Medicine (Labmed), ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Kalsum S; Center for Infectious Medicine (CIM), Department of Medicine, ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Groenheit R; Department of Microbiology, Public Health Agency of Sweden , Solna, Sweden.
  • Schön T; Department of Clinical and Experimental Medicine, Linköping University, Linköping, and Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar, Sweden.
  • Agerberth B; Clinical Microbiology, Department of Laboratory Medicine (Labmed), ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Bergman P; Clinical Microbiology, Department of Laboratory Medicine (Labmed), ANA Futura, Karolinska Institutet, Huddinge, Sweden.
  • Brighenti S; Center for Infectious Medicine (CIM), Department of Medicine, ANA Futura, Karolinska Institutet, Huddinge, Sweden.
J Infect Dis ; 224(2): 332-344, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33606878

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Colecalciferol / Agentes Inmunomoduladores / Péptidos Antimicrobianos Límite: Humans Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Colecalciferol / Agentes Inmunomoduladores / Péptidos Antimicrobianos Límite: Humans Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Suecia